DEFM14A: The Doctors Company to Acquire ProAssurance for $25 Per Share in Cash

ProAssurance stockholders will receive $25 per share in cash as The Doctors Company acquires the company in a merger transaction.

Summary

• ProAssurance Corporation is set to be acquired by The Doctors Company in a merger agreement dated March 19, 2025.
• Under the terms of the agreement, ProAssurance stockholders will receive $25.00 in cash for each share of common stock they own.
• This represents a premium of approximately 58.8% over ProAssurance's closing stock price on March 18, 2025.
• The transaction is subject to stockholder approval, regulatory approvals, and other customary closing conditions.
• A special meeting of ProAssurance stockholders is scheduled for June 24, 2025, to vote on the merger agreement.
• The ProAssurance Board of Directors unanimously recommends that stockholders vote in favor of the merger agreement.
• The merger is expected to close during the first half of 2026.
• Upon completion of the merger, ProAssurance will become a wholly-owned subsidiary of The Doctors Company and its stock will be delisted from the NYSE.

Sentiment

Score: 8

Explanation: The document is positive due to the significant premium offered to ProAssurance stockholders and the unanimous recommendation of the Board of Directors. However, there are risks associated with regulatory approvals and potential disruptions to the business.

Positives

• Stockholders will receive a significant premium of 58.8% over the recent stock price.
• The all-cash deal provides certainty of value for ProAssurance stockholders.
• The ProAssurance Board of Directors supports the merger.
• Goldman Sachs delivered a fairness opinion.
• The Doctors Company has committed to providing sufficient funds to complete the merger.

Negatives

• The merger is subject to regulatory approvals, which could delay or prevent the transaction.
• ProAssurance will no longer exist as an independent public company.
• Stockholders will not participate in any future growth of ProAssurance.
• The merger agreement includes a termination fee of $52.6 million payable by ProAssurance under certain circumstances.

Risks

• Failure to obtain stockholder or regulatory approvals.
• Potential delays in closing the merger.
• Possible litigation challenging the merger.
• Disruptions to ProAssurance's business during the pendency of the merger.
• Inability to retain key personnel.
• Adverse reactions from business relationships.
• Changes in legislation, regulation, or economic conditions.

Future Outlook

ProAssurance expects to complete the merger during the first half of 2026, subject to regulatory and stockholder approvals and other customary closing conditions.

Management Comments

• The ProAssurance Board has determined that the merger agreement and the transactions contemplated thereby, including the merger, are in the best interests of ProAssurance and the ProAssurance stockholders.
• The ProAssurance Board unanimously recommends that you vote FOR the proposal to adopt the merger agreement.

Industry Context

The acquisition of ProAssurance by The Doctors Company reflects ongoing consolidation trends within the medical professional liability insurance industry, as companies seek to expand their market presence and diversify their offerings.

Comparison to Industry Standards

• The merger consideration of $25.00 per share represents a premium of 58.8% over ProAssurance's closing stock price on March 18, 2025, which is a significant premium compared to other recent transactions in the insurance industry.
• Comparable companies in the medical professional liability insurance sector include Medical Protective, a Berkshire Hathaway company, and Coverys, a physician-owned insurer.
• The Doctors Company's acquisition of ProAssurance is similar to other recent mergers in the insurance industry, such as the acquisition of Argo Group International Holdings by Brookfield Reinsurance Ltd. in February 2023.

Stakeholder Impact

• ProAssurance stockholders will receive $25.00 per share in cash.
• ProAssurance employees will be offered comparable compensation and benefits for at least 12 months following the merger.
• The Doctors Company will expand its market presence and diversify its offerings.
• Customers may experience changes in service and product offerings as a result of the merger.
• Suppliers and creditors may be affected by the change in ownership and business strategy.

Next Steps

• ProAssurance stockholders will vote on the merger agreement at a special meeting on June 24, 2025.
• The companies will seek regulatory approvals for the merger.
• The companies will work to satisfy other closing conditions outlined in the merger agreement.
• If all conditions are met, the merger is expected to close during the first half of 2026.

Key Dates

Keywords

merger agreement, ProAssurance, acquisition, The Doctors Company, stockholders, merger, PRA, insurance